Cambridge Healthtech Institute’s Inaugural Training Seminar

Immunology for Biotherapeutics

Understanding and Exploiting the Immune System

October 24-25, 2017


This new training seminar will examine the roles of the various cells involved in the immune response and how they can be manipulated and harnessed for therapeutic purposes, including the role of innate immunity, which is increasingly recognized as having an important role. Attendees will learn about immunotherapy approaches such as modification of T cell function, controlling checkpoint inhibitors, and the CAR-T, TIL and TCR lines of attack, while stressing the safety aspects of immunotherapy. They will also hear about autoimmune disorders, and current approaches with vaccines. The value and limitations of preclinical models will be examined and, of particular relevance to this event, we will examine the impact of immunogenicity on safety and efficacy of biotherapeutics.

Introduction to Immunology for Biotherapeutics and the Role of T Regulatory Cells

Ethan Shevach, M.D., Senior Investigator, Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Immunology Safety Considerations for Biotherapeutics

Rakesh Dixit, Ph.D., Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune, Inc.

The Impact of Immunogenicity on Safety and Efficacy of Biotherapeutics

Bonnie Rup, Ph.D., Bonnie Rup Consulting

Applying Bispecific Technology to Modulate the Immune Response for Therapeutic Intervention

Paul Moore, Ph.D., Vice President, Immunology and Cell Biology, Macrogenics, Inc.

For more details on the conference, please contact:
Nicole Lyscom Ph.D. 
Senior Conference Director
Cambridge Healthtech Institute
Tel: +44 7791 866489
For exhibit & sponsorship opportunities, please contact:
Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
Tel: 781-972-5412



Register Now

Download the Brochure

Sponsorship and Exhibit

Conference at a glance

Celebrating 25 years